CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative DiseaseConstanze Slabik, Renata Stripecke|Molecular Therapy — Oncolytics|2020Cited by 77